2024
1140-P: Impact of Empagliflozin on Hyperfiltration in Youth with Type 2 Diabetes—Post Hoc Analysis of the DINAMO and DINAMO MONO Trials
BJORNSTAD P, DANNE T, TAMBORLANE W, KLINGENSMITH G, SCHUELER E, TARTAKOVSKY I, MARQUARD J, ZEITLER P, WILLI S, LAFFEL L. 1140-P: Impact of Empagliflozin on Hyperfiltration in Youth with Type 2 Diabetes—Post Hoc Analysis of the DINAMO and DINAMO MONO Trials. Diabetes 2024, 73 DOI: 10.2337/db24-1140-p.Peer-Reviewed Original ResearchDiabetic kidney diseaseKidney diseaseHoc analysisDiabetic kidney disease riskEarly diabetic kidney diseaseBaseline to weekImpact of empagliflozinCystatin C equationClinically relevant improvementNational Institute of DiabetesDigestive and Kidney DiseasesPost hoc analysisEGFR changeIncreased riskHyperfiltrationPubertal statusGlycemic controlEGFRC equationLong-term effectsPotential long-term effectsRelevant improvementNormofiltrationT2DHealthy youth
2023
1162-P: Promoting Career Development of Physicians Engaged in Type 1 Diabetes (T1D) Research—The New DiabDocs Multicenter National K12 Program
DASANI K, BISHOP F, GOLDEN S, LAFFEL L, MIRMIRA R, STECK A, TAMBORLANE W, WILLI S, MAAHS D, DIMEGLIO L. 1162-P: Promoting Career Development of Physicians Engaged in Type 1 Diabetes (T1D) Research—The New DiabDocs Multicenter National K12 Program. Diabetes 2023, 72 DOI: 10.2337/db23-1162-p.Peer-Reviewed Original ResearchK12 programEffects of mentoringProductive academic careerPromote career developmentLetter of intentMentoring communityAcademic careerCareer trajectoriesCareer developmentProgram administratorsPhysician-scientistsRate of physiciansDiversity trainingProgram trainingLeadership CommitteeTraining experienceScientific Review CommitteeDigestive and Kidney DiseasesResearch supportInstitutionsCareerDiabetes InstituteNationwide cohortProgramAdvisory Panel